Exciting Times in the World of Proteomics! Thermo Fisher Scientific’s remarkable $3.1 billion acquisition of Olink Proteomics is a testament to the incredible technology that forms the foundation of Olink Proteomics. Olink’s advancements in proteomics have significant impacts on both ongoing drug discovery and future precision medicine. Navinci and Olink Proteomics share the same ancestry,…
Illuminate PD1/PD-L1 interactions – new product out! 23-06-12 Uppsala Navinci expands its portfolio to unravel PD1 signaling, introducing the fluorescent assay, Naveni™ PD1/PD-L1 Atto 647N. With Naveni™ PD1/PD-L1 Atto 647N, you can now achieve a comprehensive visualization of the tumor microenvironment through co-staining. Illuminate PD1/PD-L1 interactions like never before and gain a deeper understanding of…
Navinci at EACR 2023 Congress – Unleashing Innovation 23-06-12 Uppsala A new product will be unveiled at the EACR Congress, where the Navinci team, consisting of Ida Hansson (Scientific Sales Specialist), Eva Auieong (Laboratory Manager), Hampus Elofsson (Senior Scientist), and Daniel Ekman (Customer Support Manager), will showcase our latest developments at booth 79. Make sure…
Navinci at AACR – new research data and product developments 31-03-2023 Uppsala Navinci will attend AACR on April 14-19th in Orlando, US. We will showcase our latest product designs and tell you what is new in protein-protein interaction technology. You can find us in the exhibition hall (booth 1771) and at the scientific sessions with four poster presentations including…
Exhibition at SciLifeLab 23-03-29 Uppsala Are you in Uppsala? Stop by BMC, Navet, and the Life Science exhibition! We will be there on March 30th, between 09.00-15.00, this is a chance to receive information and updates from us and 9 others of the leading life science companies in Sweden (and to get some goodies). SciLifeLab…
Seminar: How to detect protein-protein interactions – Latest innovations in Proximity Ligation Technology March 15th, Biomedicum D1012 Karolinska Institutet, Solna Sweden We’re excited to invite you to our in-person seminar! In this session, you will learn how to visualize protein interplay in situ and how the latest Naveni proximity ligation technologies are pioneering molecular biology research. …
Navinci Diagnostics AB appoints Eva Pisa as chairman, further strengthens the leadership team, and establishes a Scientific Advisory Board In line with the company’s vision of becoming a leader in spatial proteomics, Navinci further strengthens its organization and is pleased to announce the appointment of Dr. Eva Pisa as new chairman of the board, Dr.…